KRAS and malignant colon neoplasm: A previous study comparing gene expression profiles for colon cancer cells with or without oncogenic KRAS identified EREG to be significantly upregulated by the activated KRAS signaling pathway, and the forced expression of exogenous EREG enhanced in vivo tumorigenicity in a colon cancer xenograft model [83].